Search

You searched for "lashes"

2093 results found

Non-infectious Uveitis: Well Known, Weird and Wonderful meets You, Me and the Balloons

3 August 2023 | | EYE - Vitreo-Retinal
Installation view from Manchester International Festival 2023 exhibition Yayoi Kusama: You, Me and the Balloons at Aviva Studios. Images © David Levene. On an uncharacteristically salubrious 5 July 2023, the date of the 75th Anniversary of the UK’s NHS, a...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Tips for maximising your ophthalmology elective in the UK as an international medical student

4 August 2025 | | EYE - General
Practical strategies for international medical students to maximise their ophthalmology elective in the UK, including networking, skill building and research opportunities. An ophthalmology elective is an incredible opportunity to gain hands-on experience, develop clinical skills and connect with professionals in...

Large language models in ophthalmology

3 October 2024 | | EYE - General
Traditional artificial intelligence (AI) models typically require large amounts of labelled data for training. For example, to develop a model capable of detecting macular pathologies on optical coherence tomography scans, thousands of scans would need to be manually labelled by...

Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept

2 March 2026 | | EYE - Imaging, EYE - Vitreo-Retinal
This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...

Deliberate darkness: The systematic weaponisation of blinding in global protests

18 March 2026 | | EYE - General
As eyecare professionals, we spend our entire professional lives fighting to preserve light. We train to master the delicate microscopic topography of the cornea, the retina and the optic nerve, all with the objective of saving our patients from the...

A trip up north: Eye News Symposium 2020

24 February 2020
New accents, friendly smiles and haggis served with my traditional morning breakfast, I knew at this point that I was a long way from the south of England, where this story begins.

Javier Bardem 'donates' his iris to the Eyes of the World Foundation to fight avoidable blindness

21 September 2022
The Eyes of the World Foundation has launched 'Iris of the World' to raise awareness of the deficiencies in eye care in the most vulnerable areas of the world, and to defend the universal right to vision.

Orbis marks 100-millionth antibiotic dose in the fight against trachoma in Ethiopia

12 May 2023 | Orbis, antibiotics, trachoma, Ethiopia
Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

18 September 2023 | Glaucoma, CID, Ciliatech, Research
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

Blind woman left traumatised after she feared falling in front of speeding train

26 September 2023 | RNIB, Sight Scotland, Traumatic experience, Samantha Gough, Football, Train strikes, travel
A blind woman footballer from Edinburgh was left traumatised after she feared falling in front of a speeding train when rail staff never showed up to help her.

Effective treatment for rare sight-threatening infection

1 November 2023 | Moorfields, UCL, SIFI S.p.A., Acanthamoeba, keratitis, corneal infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.